Report overview
The global Irritable Bowel Syndrome Treatment Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Antibiotics Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Irritable Bowel Syndrome Treatment Drug include Abbvie Inc., Bristol Myers Squibb, Roche, Johnson & Johnson, Pfizer Inc., Prometheus Laboratories Inc. (Nestle), Bausch Health, Takeda Pharmaceutical Ltd and Biogen, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Irritable bowel syndrome (IBS) is?a common condition that affects the digestive system. It causes symptoms like stomach cramps, bloating, diarrhoea and constipation. These tend to come and go over time, and can last for days, weeks or months at a time. It's usually a lifelong problem.
This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome Treatment Drug. This report contains market size and forecasts of Irritable Bowel Syndrome Treatment Drug in global, including the following market information:
Global Irritable Bowel Syndrome Treatment Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Irritable Bowel Syndrome Treatment Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Irritable Bowel Syndrome Treatment Drug Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Irritable Bowel Syndrome Treatment Drug Market Segment Percentages, by Type, 2023 (%)
Antibiotics
Amino Salicylates
Corticosteroids
Immunomodulators
Others
Global Irritable Bowel Syndrome Treatment Drug Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Irritable Bowel Syndrome Treatment Drug Market Segment Percentages, by Application, 2023 (%)
Hospitals
Specialty Clinics
Other
Global Irritable Bowel Syndrome Treatment Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Irritable Bowel Syndrome Treatment Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Irritable Bowel Syndrome Treatment Drug revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Irritable Bowel Syndrome Treatment Drug revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie Inc.
Bristol Myers Squibb
Roche
Johnson & Johnson
Pfizer Inc.
Prometheus Laboratories Inc. (Nestle)
Bausch Health
Takeda Pharmaceutical Ltd
Biogen
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Irritable Bowel Syndrome Treatment Drug, market overview.
Chapter 2: Global Irritable Bowel Syndrome Treatment Drug market size in revenue.
Chapter 3: Detailed analysis of Irritable Bowel Syndrome Treatment Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Irritable Bowel Syndrome Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
